Thrombotic diseases, in particular cardiovascular and cerebrovascular thrombotic diseases, have become the top cause of death in the population of China, and their incidence has increased, seriously endangering human health.

China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

On June 14, Zhang Wei, CEO & president of Huawei Sports and health product line said that by the end of 2021, Huawei's cumulative global shipments of wearables had exceeded 100 million, and the cumulative global users had exceeded 350 million.

PerkinElmer on Thursday announced it is collaborating with Novartis to expand newborn screening for sickle cell disease in sub-Saharan Africa.

The World Health Organization's COVID-19 Technology Access Pool (C-TAP) initiative has entered into a nonexclusive sublicense agreement with Biotech Africa to manufacture a serology assay to detect previous SARS-CoV-2 infection.

On June 9, 2022, Siemens Healthineers China officially released the company's new "National Intelligence Innovation" localization strategy, announcing that it will deeply participate in Healthy China construction as a "Chinese company" through three demensions.

Thermo Fisher Scientific said on Wednesday that it has received CE-IVD marking for its Ion Torrent Reporter Software Aneuploidy Dx Workflows.

Roche said on Wednesday that the US Food and Drug Administration has issued Emergency Use Authorization for the Cobas SARS-CoV-2 Duo assay.

On June 11, 2022, the signing ceremony of the strategic cooperation between Zhengzhou Autobio Diagnostics Co., Ltd. and Pro-med (Beijing) Technology Co., Ltd. was held in Zhengzhou, and the two parties officially launched the strategic cooperation.

Digital pathology company Proscia announced on Tuesday that it has raised $37 million in a Series C financing round.

Sophia Genetics said that it has received CE-IVD marking for analytics functionality of its core Sophia Data Driven Medicine (DDM) software platform. The Swiss-American firm made the announcement Tuesday at the European Society of Human Genetics conference in Vienna.

Currently, there is a shortage of monkeys in the china pharmaceutical industry, and pharmaceutical R & D enterprises are purchasing lab monkeys on a large scale.